Treatment Persistence with Combination Eye Drops for Glaucoma: A Longitudinal Analysis Using Japanese Medical Claims Data
Kenji Kashiwagi, Miyuki Matsukawa, Rikiya Toda, Kana Okamoto, Daisaku Michikami · 2026
Read Treatment Persistence with Combination Eye Drops for Glaucoma: A Longitudinal Analysis Using Japanese Medical Claims Data by Kenji Kashiwagi, Miyuki Matsukawa, Rikiya Toda, Kana Okamoto, Daisaku Michikami (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13315027.txt.
Description
Kenji Kashiwagi, Miyuki Matsukawa, Rikiya Toda, Kana Okamoto, and Daisaku Michikami study how long glaucoma patients stay on mixed eye drops in work dated two thousand twenty-six. Glaucoma slowly harms sight, and steady use of pressure-lowering drops helps prevent that harm. Data on how long patients persist with drops that mix two drugs were lacking.
The team used health claims data from Japan for adults who began treatment soon after diagnosis, from two thousand twenty to two thousand twenty-three. One group alone held more than twenty-eight thousand patients on a paired drug mix. Stay rates at one year varied by what else was used with the mix. The study also weighs bottle counts and added drugs as factors in persistence.
Catalog record
| CREATOR | Kenji Kashiwagi, Miyuki Matsukawa, Rikiya Toda, Kana Okamoto, Daisaku Michikami |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 43 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |